Long-Term Efficacy and Safety of Ublituximab in Relapsing Multiple Sclerosis: Results from 6 Years of ULTIMATE I and II Open-Label

Drug Category : Array
Conference Category : Array
Lead Author : Cree B, et al.
Published Date : 24/09/2025
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2025/09/6_Years_OLE.ECTRIMS_2025.Platform.Cree_Final.pdf
Download Text :
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top